Bayer Challenges J&J’s Real-World Data Analysis For Erleada Survival Advantage Claims

Chess piece
Bayer's false advertising lawsuit against J&J came in the midst of a tight competitive market for the firms' prostate cancer treatments. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Marketing & Advertising

More from United States